Label: STEM CELL WHITENING SERUM- niacinamide liquid

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: unapproved drug other

DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

Drug Label Information

Updated April 6, 2011

If you are a consumer or patient please visit this version.

View All Sections
  • ACTIVE INGREDIENT

    active ingredient: adenosine
  • INACTIVE INGREDIENT

    inactive ingredient: water, human bone marrow stem cell conditioned media, butylene glycol, glycerin, alcohol denat, beta-glucan, sodium hyaluronate, hamamelis virginiana leaf extract, betaine, peg-60 hydrogenated castor oil, polyglutamic acid, lecithin, carnosine, glutathione, zanthoxylum piperitum fruit extract, pulsatilla koreana extract, usnea barbata extract, 1,2-hexanediol, caprylyl glycol, fragrance, disodium edta, oligopeptide-28, sh-decapeptide-7, caffeoyl tripeptide-1, sh-pentapeptide-198, sh-octapeptide-4, acetyl hexapeptide-22, acetyl hexapeptide-8
  • PURPOSE

    to improve wrinkle
  • KEEP OUT OF REACH OF CHILDREN

    keep out of reach of the children
  • INDICATIONS & USAGE

    - cleansing the skin
    - dispense an amount on the palm
    - smooth gently over the face and tap softly to absorb
  • WARNINGS

    - do not use when you feel itching
    - do not swallow
    - clean the skin before use
  • DOSAGE & ADMINISTRATION

    for external use only
  • PRINCIPAL DISPLAY PANEL

    package label
  • INGREDIENTS AND APPEARANCE
    STEM CELL WHITENING SERUM 
    niacinamide liquid
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:76071-3001
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    NIACINAMIDE (UNII: 25X51I8RD4) (NIACINAMIDE - UNII:25X51I8RD4) NIACINAMIDE0.02 mL  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    BUTYLENE GLYCOL (UNII: 3XUS85K0RA)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    ALCOHOL (UNII: 3K9958V90M)  
    BETADEX (UNII: JV039JZZ3A)  
    HYALURONATE SODIUM (UNII: YSE9PPT4TH)  
    HAMAMELIS VIRGINIANA BARK (UNII: IH3063S9MY)  
    BETAINE (UNII: 3SCV180C9W)  
    POLYOXYL 60 HYDROGENATED CASTOR OIL (UNII: 02NG325BQG)  
    LECITHIN, SOYBEAN (UNII: 1DI56QDM62)  
    CARNOSINE (UNII: 8HO6PVN24W)  
    GLUTATHIONE (UNII: GAN16C9B8O)  
    ZANTHOXYLUM PIPERITUM FRUIT PULP (UNII: 7PFC2VA251)  
    USNEA BARBATA (UNII: D6DVA9TCAP)  
    CAPRYLYL GLYCOL (UNII: 00YIU5438U)  
    EDETATE DISODIUM (UNII: 7FLD91C86K)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:76071-3001-13 mL in 1 SYRINGE, PLASTIC
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    unapproved drug other04/06/2011
    Labeler - Medon Co., Ltd (557802532)
    Registrant - Medon Co., Ltd (557802532)
    Establishment
    NameAddressID/FEIBusiness Operations
    Medon Co., Ltd557802532manufacture
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!